-transparent.png){kind=logo}
Ustiloxin A is a modified peptide derived from false smut balls on rice panicles, caused by the fungus Ustilaginoidea virens; structurally, it resembles phomopsin A. Ustiloxin A is cytotoxic and is an inhibitor of microtubule assembly in vitro. Because of its resemblance to phomopsin A, we examined its interaction with tubulin and compared the results with those obtained with phomopsin A and dolastatin 10, both of which were found previously to have very similar effects. We determined that ustiloxin A inhibited the formation of a particular intra-chain cross-link in beta-tubulin, as do vinblastine, maytansine, rhizoxin, phomopsin A, dolastatin 10, halichondrin B and homohalichondrin B; this is in contrast to colchicine and podophyllotoxin which do not inhibit formation of this cross-link. Ustiloxin A also inhibited the alkylation of tubulin by iodo[14C]acetamide, as do phomopsin A and dolastatin 10; vinblastine was almost as potent as inhibitor of alkylation as ustiloxin A, whereas maytansine, halichondrin B and homohalichondrin B have little or no effect. In addition, ustiloxin A inhibited exposure of hydrophobic areas on the surface of the tubulin molecule. In this respect, ustiloxin A was indistinguishable from phomopsin A but slightly more effective than dolastatin 10 and considerably more effective than vinblastine; this provides a strong contrast to maytansine, rhizoxin, and homohalichondrin B which have no effect on exposure of hydrophobic areas and to halichondrin B which enhances exposure. Lastly, ustiloxin A strongly stabilized the binding of [3H]colchicine to tubulin. The combination of ustiloxin A with cholchicine stabilized tubulin with a half-life of over 8 days, comparable with results obtained with phomopsin A and colchicine. A comparison of the structures of ustiloxin A, phomopsin A and dolastatin 10 raised the possibility that the strong stabilization of the tubulin structure may require a short segment of hydrophobic amino acids such as the modified valine-isoleucine sequence present in all three compounds. The rest of the structure, specifically the large ring of ustiloxin A and phomopsin A, may serve to place this sequence in an appropriate conformation to interact with tubulin.
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
July 1990,
Cancer research,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
April 1996,
Biochemical pharmacology,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
July 1989,
Archives of biochemistry and biophysics,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
April 1985,
Biochemical and biophysical research communications,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
April 1994,
Biochemical pharmacology,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
June 1987,
European journal of biochemistry,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
February 1992,
Biochemical pharmacology,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
February 1997,
Journal of protein chemistry,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
December 1978,
Biochimica et biophysica acta,
R F Ludueńa, and
M C Roach, and
V Prasad, and
M Banerjee, and
Y Koiso, and
Y Li, and
S Iwasaki
January 1993,
Biochemical pharmacology,
